Articles tagged with Adverse Reactions
Daily aspirin use offers no quick or reliable way to prevent bowel cancer in the general population, increasing risk of serious bleeding. However, it may have potential long-term benefits for people at high genetic risk of colorectal cancer.
An updated Cochrane review of 21 clinical trials involving over 2,100 adults found no high-quality evidence that cannabis-based medicines reduce neuropathic pain more than placebo. Small improvements were reported by patients using products with both THC and CBD, but these changes were not clinically meaningful.
A study published in JAMA found that cryopreserved platelets were less effective than liquid-stored platelets in achieving hemostasis, particularly at 24 hours after ICU admission. The research suggests that alternative storage methods may be needed for efficient surgical bleeding treatment.
Researchers at UT Health San Antonio School of Dentistry are studying novel targets and approaches to treat oral squamous cell carcinoma, the most common type of oral cancer. The studies aim to reduce pain management and mucositis in patients undergoing radiotherapy.
A novel therapeutic candidate has been developed to treat severe cutaneous adverse reactions such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). The compound suppresses disease-specific keratinocyte death, demonstrating its efficacy in preclinical studies.
Researchers developed a deep learning model to predict ADRs using molecular structures, achieving high accuracy in detecting rare effects and minimal risk for novel molecules. The model demonstrated potential as a decision-support tool in early-phase drug discovery and regulatory safety monitoring.
A new study found that childhood adversity affects how people respond to both good and bad events, leading to stronger emotional reactions to problems and reduced happiness from positive experiences. Researchers hope this understanding can help individuals self-regulate and adapt to their daily lives.
A study found that genetic variants in three genes (CYP2C19, CYP2D6, SLCO1B1) can lead to adverse reactions in up to 75% of cases. This could allow for personalized prescribing and reduce ADRs by three quarters.
NalaGenetics' nationwide genetic screening program will screen up to 16,000 leprosy patients annually for the HLA-B*13:01 biomarker. This initiative builds on a successful pilot test and marks a significant step forward in global efforts to eliminate leprosy.
A novel study found that the TPMT∗8 allele is associated with reduced metabolism of thiopurine drugs, which can lead to toxicity. The research emphasizes the importance of understanding the function of TPMT∗8 to ensure effective pharmacogenomic testing across all ancestries.
A new study reveals that etizolam and gabapentinoids contribute to a rising culture of polydrug use and increased drug-related deaths in Scotland. The analysis of 18 studies found a significant increase in gabapentinoid-related deaths, primarily due to concurrent opioid use.
Researchers found that supplementing potassium only when levels fell below 3.6 mEq/L was noninferior to the current practice of maintaining higher levels, with no increase in adverse outcomes. Lower thresholds did not worsen clinical outcomes or dysrhythmias.
A recent study found that synthetic opioid drug overdoses are becoming increasingly common in Australia, particularly due to the presence of fentanyl. The researchers highlighted the need for safe consumption spaces and increased awareness about the risks of fentanyl contamination.
A disproportionality analysis of World Health Organization data revealed a signal of semaglutide-associated suicidal ideation, particularly among patients with co-reported antidepressant use. This finding warrants urgent clarification and highlights the need for further research on the safety profile of semaglutide.
Two classes of commonly prescribed oral antibiotics are associated with the greatest risk for severe drug rashes that can lead to emergency department visits, hospitalizations, and even death. Researchers suggest using lower-risk antibiotics when clinically appropriate.
Commonly prescribed oral antibiotics increase risk of serious cutaneous adverse drug reactions compared to macrolides. Sulfonamides and cephalosporins carry the highest risk, prompting prescribers to opt for lower-risk alternatives when clinically appropriate.
A cohort study found that prenatal cannabis use was associated with several negative maternal health outcomes during pregnancy. The study emphasizes the need for further research on how different aspects of prenatal cannabis use may impact these associations.
A study by Chiba University researchers reveals that a specific variant of the HLA gene can trigger an endoplasmic reticulum stress response in skin cells when exposed to certain drugs, leading to drug eruptions. This newfound knowledge may form the basis for innovative treatment options.
A new study finds mail-order pharmacy dispensing of mifepristone for medication abortion is effective, acceptable to patients, and feasible. This care model can improve access to medication abortion services and reduce the need for in-person screening.
A recent study found a significant association between COVID-19 vaccine adverse events and political party affiliation. The more Republican states were, the higher the reported adverse events among vaccine recipients and clinicians.
A study by Washington State University found that cats with the MDR1 genetic mutation are at high risk of experiencing serious adverse effects from products containing eprinomectin. Cats without this mutation appear safe when using these products, but many cases of severe reactions have been reported.
A University of Alberta-led international network is studying very rare adverse events after vaccination, using cutting-edge techniques and unprecedented data from around the world. The goal is to enhance vaccine safety assessment and inform health authorities on the most appropriate type of vaccine for specific outbreak settings.
Outdated medical tools cause delayed recognition and management of adverse reactions in patients of color, leading to significant distress. A more inclusive approach is urgently needed to address structural racism in radiotherapy treatment and education.
A single dose of zilebesiran safely and effectively lowered systolic blood pressure in people with mild-to-moderate high blood pressure for up to six months. The study found significant reductions in daytime and nighttime systolic blood pressure, as well as low rates of adverse events.
Researchers developed a promising strategy to reduce adverse reactions to nanoparticles by using complement inhibitors. The study showed that regulators being studied effectively inhibited complement activation by nanoparticles in human serum in vitro and animal models.
A team of Chinese and UK researchers has identified superoxide dismutase 1 (SOD1) as a potential target for reversing drug resistance in ovarian cancer. By using nanoparticles to deliver siRNA that reduces SOD1 levels, the study showed reduced growth and decreased resistance to cisplatin in female mice.
A case study published in the Journal of Alzheimer's Disease reveals that lecanemab can lead to therapy-induced Aβ phagocytosis and multifocal intracerebral hemorrhage, highlighting a potential risk of brain damage and death. The study suggests that better biomarkers are needed to assess the extent of cerebral amyloid angiopathy.
Patients using medical cannabis reported sustained improvements in health-related quality of life in the study. Adverse events were common but rarely serious, highlighting the need for caution when prescribing medical cannabis.
A KAIST research team has developed an advanced AI-based drug interaction prediction technology that analyzed the interaction between Paxlovid ingredients and other prescription drugs. The study identified potential drug-drug interactions and alternative drugs with low adverse effects, which can aid in developing new treatments.
Researchers developed a new prototype treatment using a human antibody that neutralizes neurotoxins from African and Asian elapid snakes, with potential for broader cross-reactivity. The treatment showed promising results in preventing death from venom envenoming in mice.
A new study found that tailoring medication doses to a patient's DNA leads to a 30% reduction in serious side effects. The 'DNA medication pass' allows doctors and pharmacists to adjust prescriptions based on a patient's genetic profile, resulting in improved effectiveness and safety.
A study found that immune checkpoint inhibitors enhance chemotherapy-induced neuropathic pain by blocking interaction between macrophages and neurons via PD1-PDL1 synergy. This discovery could lead to the development of therapeutic alternatives to prevent pain while maintaining anti-neoplastic effects.
A systematic review and meta-analysis of 17 studies found mRNA COVID-19 vaccination to be associated with lower risks of SARS-CoV-2 infections, severe illnesses, and hospitalizations. While vaccination was linked to higher adverse event rates, the frequency of severe adverse events remained low.
A multicenter study found that COVID-19 vaccination following multisystem inflammatory syndrome (MIS-C) is safe, with mild reactions and no serious complications. The study included 385 patients aged 5 years or older, all of whom received at least one vaccine dose without any reports of myocarditis or MIS-C reoccurrence.
A comprehensive review and meta-analysis found that young adults under 40 have a slightly elevated risk for myocarditis or pericarditis after mRNA COVID-19 vaccination. The analysis analyzed data from over 58 million participants and explored the relationship between COVID-19 vaccine and these rare but dangerous adverse reactions.
Researchers assessed the safety and adverse events of mRNA COVID-19 vaccines in long-term care residents in Quebec, Canada. No significant adverse events were reported following the third dose, highlighting the vaccine's effectiveness in this vulnerable population.
A study of 980,000 people found that simultaneous administration of COVID-19 mRNA booster and seasonal influenza vaccines was associated with significant increases in reports of systemic reactions. The study suggests that the combination may lead to more severe adverse events, highlighting the need for further research.
A study by the University of Liverpool found that polypharmacy and multimorbidity are linked to an increasing burden of adverse drug reactions, with 16.5% of hospital admissions caused by medicine-related harm. The researchers call for a whole-systems approach to address overprescribing and improve patient care.
A recent study found that older adults who received a booster dose of the Pfizer-BioNTech COVID-19 vaccine experienced short-term adverse events. The study assessed over 60,000 participants aged 60 or older in Israel and reported various side effects including fatigue, headache, and muscle pain.
A study of 48,000 individuals found that third-dose vaccination against SARS-CoV-2 with mRNA vaccines was associated with increased reporting of low-severity adverse events. However, there was no significant increase in the reporting of severe adverse events.
Researchers at Okayama University have created a new method to kill cancer cells using light-activated protein AR3, reducing the risk of adverse reactions. The approach uses green light to trigger apoptosis in targeted cells, offering a promising alternative to conventional treatments.
A Rutgers analysis of Medicare database found that two IV iron formulations have a much higher chance of provoking severe allergic attacks. The risk was highest for iron dextran and ferumoxytol, with rates three to eight times higher than ferric gluconate.
Researchers at TTUHSC developed novel hydrophilic nanoparticles that target bacterial membranes, killing pathogens while sparing mammalian cells. The nanoantibiotics' size-dependent activity reveals a new blueprint for developing non-toxic and environmentally friendly antibiotics.
Researchers at the University at Buffalo have developed a new treatment that pairs essential proteins with lysophosphatidylserine to build immune tolerance and prevent antibody development, potentially treating autoimmune disorders and allergies.
A retrospective study of over 3,900 patients found that warming iohexol 350 contrast media did not significantly reduce adverse reactions or extravasations. The results suggest that maintaining the agent at room temperature is non-inferior to warming it to body temperature before injection.
The study uses natural language processing to extract adverse effects from Spanish health records, highlighting a major health problem and improving clinical decision making. The system learns more effectively with larger corpora, contributing to closing the gap in clinical text mining across languages.
A simple nurse- or carer-led medicines' monitoring system has been shown to reduce medication-related illness in people living in residential care homes. The Adverse Drug Reaction Profile (ADRe-p) system helped identify medicines' mismanagement and adverse drug reactions, leading to improved prescribing and reduced harm.
A study presented at ACR Convergence found that adults with systemic lupus erythematosus who receive TMP-SMX are at high risk for adverse reactions. Lupus patients with anti-Smith antibodies were significantly associated with a higher risk of an adverse drug reaction.
A new open-source machine learning tool identifies proteins associated with drug side effects, offering insights into how the human body responds to drug compounds. The algorithm has generated 221 associations between individual proteins and specific adverse drug reactions.
A recent study by Washington State University researchers found that more than 50% of college students reported experiencing coughing fits, anxiety, and/or paranoia while using cannabis. The study also identified the most distressing adverse reactions, which included panic attacks, fainting, and vomiting.
A study published in CMAJ found that heart disease increases the risk of hospitalization for allopurinol-related severe skin reactions. People with specific genetic markers, such as HLA-B*5801, are at higher risk. The risk is further increased when combined with kidney disease.
Researchers identified discrepancies in 363 reports (15%) of adverse drug reactions between men and women. Drugs like thyroid hormones and antidepressants showed higher frequencies among female patients.
A recent study found that over 90% of oral medications contain at least one inactive ingredient capable of causing an adverse reaction. The most common culprits include lactose, peanut oil, and gluten. These ingredients can trigger allergic or gastrointestinal symptoms in sensitive individuals.
Two clinical trials evaluate the frequency and type of adverse reactions to benznidazole in chronically infected adults. The studies found that the majority of adverse reactions (90%) were mild and appeared within the first month of treatment.
The American College of Physicians states that internet-driven pseudoscience is a major contributor to low statin adherence rates, despite their well-documented benefits. Continuing statin prescriptions after adverse reactions may reduce cardiovascular events and death risk.
A new study found that patients who continued receiving statins after experiencing an adverse reaction, such as muscle aches and pains, had a lower risk of death and cardiovascular events. The study analyzed data from 28,266 participants and found that about 70% of patients continued taking statin prescriptions.
Women are at greater risk of cardiovascular disease due to longer lifespan and differences in drug absorption, distribution, and metabolism compared to men. The European Society of Cardiology recommends sex-specific guidelines for cardiovascular drugs to minimize adverse reactions.
A comprehensive study by UBC researchers found an increased risk of stroke, migraine, depression, and abnormalities in the blood with beta interferon treatment. The study complements previous observations and highlights the need for further research on developing biomarkers to identify patients at greatest risk.
A review of studies found that most patients were unaware of reporting systems and others were confused about reporting. Patients who did report adverse reactions cited motivations for preventing similar suffering in others.
A study of 1000 adult patients in Singapore found that gastrointestinal-related ADRs were common, while cardiovascular drugs caused the majority. Patients with ADRs had a longer hospital stay, suggesting some ADRs may be predictable based on genetics.